Efficacy of CD19 CAR T-cell therapy in active vitreoretinal lymphoma. Takahashi H, Nakajima Y, Kaburaki T, Hamada T, et al. Leuk Lymphoma 2026 Mar 31:1-4. doi: 10.1080/10428194.2026.2650671.

Read + Share

Amedeo Smart

Independent Medical Education

Takahashi H, Nakajima Y, Kaburaki T, Hamada T, et al. Efficacy of CD19 CAR T-cell therapy in active vitreoretinal lymphoma. Leuk Lymphoma 2026 Mar 31:1-4. doi: 10.1080/10428194.2026.2650671.
PMID: 41914977